Investment - Celularity - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Schedule of Equity Method Investments [Line Items]
Common stock, shares outstanding (in shares)	551,281,154		551,281,154		522,817,137
Celularity
Schedule of Equity Method Investments [Line Items]
Unrealized gains (losses) on marketable investments	$ (1.8)		$ (15.5)
Celularity | Restricted Shares
Schedule of Equity Method Investments [Line Items]
Unrealized gains (losses) on marketable investments		$ (92.8)		$ (26.1)
Celularity | Private Placement Shares
Schedule of Equity Method Investments [Line Items]
Unrealized gains (losses) on marketable investments		$ (2.7)		$ (0.9)
Class A Common Stock | Celularity
Schedule of Equity Method Investments [Line Items]
Common stock, shares outstanding (in shares)	20,422,124		20,422,124
Class A Common Stock | Celularity | Restricted Shares
Schedule of Equity Method Investments [Line Items]
Common stock, shares outstanding (in shares)	19,922,124		19,922,124
Class A Common Stock | Celularity | Private Placement Shares
Schedule of Equity Method Investments [Line Items]
Common stock, shares outstanding (in shares)	500,000		500,000